APA (7th ed.) Citation

KLLL, M., APN, B., OA, M., JG, M., LB, F., KRL, T., . . . V, V. (2024). Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort. Vaccines, 12(12), . https://doi.org/10.3390/vaccines12121367

Chicago Style (17th ed.) Citation

KLLL, Machado, et al. "Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort." Vaccines 12, no. 12 (2024). https://doi.org/10.3390/vaccines12121367.

MLA (9th ed.) Citation

KLLL, Machado, et al. "Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort." Vaccines, vol. 12, no. 12, 2024, https://doi.org/10.3390/vaccines12121367.